The UltraClot® formulation is a patented and FDA approved hemostatic technology originally developed for the U.S. Military to stop bleeding of major arterial wounds on the battlefield. This technology, currently in use, provides a platform for application specific products designed to control severe hemorrhage under the most adverse conditions. For more detailed information, please visit www.emeddevices.com .
UltraClot's® unique formulation wicks excess blood from the wound site while accelerating clot formation and comes in two forms - a gauze, UltraClot® Gauze, and an injectable, BallistiClot®. This same technology is now available in UltraClot® OTC designed to be used by the civilian market for the treatment of minor cuts, scratches and abrasions, effective even in people using blood thinners.
UltraClot® OTC inhibits the the growth of drug resistant bacteria such as MRSA and E. coli.
ULTRACLOT® OTC IS THE SAME LIFE SAVING FORMULA USED BY THE U.S. MILITARY
TO STOP MAJOR ARTERIAL BLEEDING
"In our experience, UltraClot® has significantly the highest user success rates." Dr. John Hagmann, M.D., PhD., Lt. Col. U.S. Army, Ret.